Cytoreductive surgery in primary advanced epithelial ovarian cancer

doi:10.5317/wjog.v2.i4.116

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4275)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

428

HTML

2166

Tables (1-1)

169

Sum=2763

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

838

Download

674

Sum=1512

Nov 10, 2013 (publication date) through Jun 17, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Obstetrics and Gynecology

ISSN

2218-6220

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Obstet Gynecol. Nov 10, 2013; 2(4): 116-123
Published online Nov 10, 2013. doi: 10.5317/wjog.v2.i4.116

Cytoreductive surgery in primary advanced epithelial ovarian cancer

Luca Ansaloni, Federico Coccolini, Fausto Catena, Luigi Frigerio, Robert E Bristow

Luca Ansaloni, Federico Coccolini, Department of General and Emergency Surgery, Ospedali Riuniti, 24128 Bergamo, Italy

Fausto Catena, Department of General and Emergency Surgery, Ospedale di Parma, 43121 Parma, Italy

Luigi Frigerio, Department of Obstetrics and Gynecology, Ospedali Riuniti, 24128 Bergamo, Italy

Robert E Bristow, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, CA 92868, United States

Author contributions: Ansaloni L, Coccolini F and Bristow RE contributed to study conception, literature analysis, manuscript writing and editing; Catena F and Frigerio L contributed to literature search and analysis.

Correspondence to: Luca Ansaloni, MD, Department of General and Emergency Surgery, Ospedali Riuniti, Largo Barozzi 1, 24128 Bergamo, Italy. lansaloni@ospedaliriuniti.bergamo.it

Telephone: +39-35-2699712 Fax: +39-35-266567

Received: December 13, 2012
Revised: February 2, 2013
Accepted: March 6, 2013
Published online: November 10, 2013

Core Tip

Core tip: The present paper reviews the efficacy of complete cytoreductive surgery in the treatment of primary advanced epithelial ovarian cancer. Outlining the importance for standard criteria in defining the completeness of cytoreduction. Moreover the biology of the tumor plays an important role in survival benefit of surgery. It’s

still undefined how the intrinsic features of the tumor make intra-abdominal implants easier to remove. Adjuvant and hyperthermic intraperitoneal chemotherapy could play a decisive role in the coming years as the completeness of macroscopic disease removal increases with advances in surgical techniques and technology.